Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

asx lgp

  • Home
  •  
  • asx lgp



  • Most Read
  • Latest Comments
  • Little Green Pharma winds down German distribution deal
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Little Green Pharma winds down German distribution deal
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Little Green Pharma winds down German distribution deal
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Little Green Pharma winds down German distribution deal
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Little Green Pharma winds down German distribution deal
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    • News

  • Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    • News

  • Melodiol moves to clear debt with $12m asset fire sale
    Melodiol moves to clear debt with $12m asset fire sale
    • News

  • Althea to make a splash in the US with new cannabis-based sodas
    Althea to make a splash in the US with new cannabis-based sodas
    • News

  • Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    • News

  • Little Green Pharma winds down German distribution deal
    • News

    Little Green Pharma winds down German distribution deal

    A key player in the global cannabis market, Little Green Pharma (ASX: LGP), has pulled the plug on its German distributor, Four 20 Pharma GmbH, after failing to meet the contract terms to bring a highly-prospective new THC strain to the German medical cannabis market by 19th November 2022. Licensed as a manufacturer, wholesaler, and

    Read More
    Public
  • Little Green Pharma to demerge its medicinal psychedelics business
    • News

    Little Green Pharma to demerge its medicinal psychedelics business

    There is an increasingly growing body of research globally into the use of psychedelic medicines to treat various health conditions. To date, this research has produced highly encouraging results and has promoted the development of an extensive psychedelic industry, which has kicked off in North America and the United Kingdom. The industry has now made

    Read More
    Public
  • Little Green Pharma enters race to treat mental illness with psychedelic medicines
    • News

    Little Green Pharma enters race to treat mental illness with psychedelic medicines

    Advancing their research and development for medicinal cannabis applications, Little Green Pharma (ASX: LGP) has joined the global movement for use of psychedelics for treatment of mental illness having secured regulatory approval to supply psilocybin. The approvals come in the form of a Schedule 9 licence granted by the WA Department of Health which enables

    Read More
    Public
  • Health Insurer adds cannabis to coverage with Little Green Pharma partnership
    • News

    Health Insurer adds cannabis to coverage with Little Green Pharma partnership

    Members of private health insurer Health Insurance Fund (HIF) will be given priority access to Little Green Pharma (ASX: LGP) and their research into medicinal cannabis with the two commencing a strategic partnership focused on improving patient quality of life.  Under the partnership, HIF members will be given priority participation in Little Green Pharma product

    Read More
    Public
  • Little Green Pharma approved to commence manufacturing cannabis products
    • News

    Little Green Pharma approved to commence manufacturing cannabis products

    Australian cannabis company Little Green Pharma (ASX: LGP) has reached a major commercial achievement in their long-term strategy having been granted a manufacturing licence for cannabis products at their newly commissioned facility in Western Australia. “The grant represents the culmination of LGP’s long-term regulatory strategy and is a clear watershed moment for the Company. The

    Read More
    Public
  • Little Green Pharma to supply medicinal cannabis to underserviced German market
    • News

    Little Green Pharma to supply medicinal cannabis to underserviced German market

    Australian medicinal cannabis and healthcare company Little Green Pharma (ASX: LGP) has this morning announced a key purchase agreement with Berlin-based DEMECAN for the sale and export of up to 1000kg of dried cannabis flower or 48,000 units of medicinal cannabis per annum. The agreement makes LGP one of the first few companies to export

    Read More
    Public
  • 1
  • 2

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.